{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T19:02:32Z","timestamp":1693940552270},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T00:00:00Z","timestamp":1253059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T00:00:00Z","timestamp":1253059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s10637-009-9313-x","type":"journal-article","created":{"date-parts":[[2009,9,15]],"date-time":"2009-09-15T02:37:44Z","timestamp":1252982264000},"page":"783-790","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["DH9, a novel PPAR\u03b3 agonist suppresses the proliferation of ADPKD epithelial cells: An association with an inhibition of \u03b2-catenin signaling"],"prefix":"10.1007","volume":"28","author":[{"given":"Moyan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xishan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changlin","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,16]]},"reference":[{"key":"9313_CR1","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1158\/1541-7786.MCR-06-0278","volume":"5","author":"FS Chou","year":"2007","unstructured":"Chou FS, Wang PS, Kulp S, Pinzone JJ (2007) Effects of thiazolidinediones on differentiation, proliferation, and apoptosis. Mol Cancer Res 5:523\u2013530","journal-title":"Mol Cancer Res"},{"key":"9313_CR2","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1158\/0008-5472.CAN-04-1677","volume":"65","author":"CW Shiau","year":"2005","unstructured":"Shiau CW, Yang CC, Kulp SK, Chen KF, Chen CS, Huang JW (2005) Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL\/Bcl-2 functions independently of PPARgamma. Cancer Res 65:1561\u20131569","journal-title":"Cancer Res"},{"key":"9313_CR3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1158\/1535-7163.MCT-05-0347","volume":"5","author":"S Han","year":"2006","unstructured":"Han S, Roman J (2006) Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways. Mol Cancer Ther 5:430\u2013437","journal-title":"Mol Cancer Ther"},{"key":"9313_CR4","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1056\/NEJMoa072761","volume":"356","author":"SE Nissen","year":"2007","unstructured":"Nissen SE, Wolski K (2007) Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356:2457\u20132471","journal-title":"N Engl J Med"},{"key":"9313_CR5","first-page":"938","volume":"357","author":"GA Diamond","year":"2007","unstructured":"Diamond GA, Kaul S (2007) Rosiglitazone and cardiovascular risk. N Engl J Med 357:938\u2013939","journal-title":"N Engl J Med"},{"key":"9313_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1056\/NEJMe078117","volume":"357","author":"DM Nathan","year":"2007","unstructured":"Nathan DM (2007) Rosiglitazone and cardiotoxicity-weighing the evidence. N Engl J Med 357:64\u201366","journal-title":"N Engl J Med"},{"key":"9313_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1056\/NEJMe078116","volume":"357","author":"BM Psaty","year":"2007","unstructured":"Psaty BM, Furberg CD (2007) The record on rosiglitazone and the risk of myocardial infarction. N Engl J Med 357:67\u201369","journal-title":"N Engl J Med"},{"key":"9313_CR8","doi-asserted-by":"crossref","unstructured":"Xiong X, Wang L, Ye Y, Fu L, Chen M, Wang Q, Liu M, Tang J, Dai B, Shen J, Mei C (2009) Pyrimidinyl-arylpropionic acid derivatives: viable resources in the development of new antineoplastic agents. Invest New Drugs [Epub ahead of print]","DOI":"10.1007\/s10637-009-9278-9"},{"key":"9313_CR9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1046\/j.1523-1755.2000.00849.x","volume":"57","author":"JJ Grantham","year":"2000","unstructured":"Grantham JJ (2000) Time to treat polycystic kidney diseases like the neoplastic disorders that they are. Kidney Int 57:339\u2013340","journal-title":"Kidney Int"},{"key":"9313_CR10","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.1074\/jbc.274.8.4947","volume":"274","author":"E Kim","year":"1999","unstructured":"Kim E, Arnould T, Sellin LK, Benzing T, Fan MJ, Gr\u00fcning W, Sokol SY, Drummond I, Walz G (1999) The polycystic kidney disease 1 gene product modulates Wnt signaling. J Biol Chem 274:4947\u20134953","journal-title":"J Biol Chem"},{"key":"9313_CR11","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1091\/mbc.E03-05-0296","volume":"15","author":"T Roitbak","year":"2004","unstructured":"Roitbak T, Ward CJ, Peter C, Harris A (2004) Polycystin-1 multiprotein complex is disrupted in polycystic kidney disease cells. Mol Biol Cell 15:1334\u20131346","journal-title":"Mol Biol Cell"},{"key":"9313_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11154-006-9003-3","volume":"7","author":"ML Johnson","year":"2006","unstructured":"Johnson ML, Rajamannan N (2006) Diseases of Wnt signaling. Rev Endocr Metab Disord. 7:41\u201349","journal-title":"Rev Endocr Metab Disord."},{"key":"9313_CR13","doi-asserted-by":"publisher","first-page":"5972","DOI":"10.1038\/sj.onc.1204825","volume":"20","author":"S Saadi-Kheddouci","year":"2001","unstructured":"Saadi-Kheddouci S, Berrebi D, Romagnolo B, Cluzeaud F, Peuchmaur M, Kahn A, Vandewalle A, Perret C (2001) Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the \u03b2-catenin gene. Oncogene 20:5972\u20135981","journal-title":"Oncogene"},{"key":"9313_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0074-7696(01)03010-8","volume":"203","author":"St AL Amand","year":"2001","unstructured":"St Amand AL, Klymkowsky MW (2001) Cadherins and catenins, Wnts and SOXs: embryonic patterning in Xenopus. Int Rev Cytol 203:291\u2013355","journal-title":"Int Rev Cytol"},{"key":"9313_CR15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2174\/1568009043332709","volume":"4","author":"H Luu Hue","year":"2004","unstructured":"Luu Hue H, Ruiwen Z et al (2004) Wnt\/\u03b2-Catenin signaling pathway as novel cancer drug targets. Current Cancer Drug Targets 4:653\u2013671","journal-title":"Current Cancer Drug Targets"},{"key":"9313_CR16","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1124\/mol.107.035287","volume":"72","author":"S Wei","year":"2007","unstructured":"Wei S, Lin LF, Yang CC, Wang YC, Chang GD, Chen H, Chen CS (2007) Thiazolidinediones modulate the expression of beta-catenin and other cell-cycle regulatory proteins by targeting the F-box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor gamma. Mol Pharmacol 72:725\u2013733","journal-title":"Mol Pharmacol"},{"key":"9313_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/CAD.0b013e328011e67d","volume":"18","author":"S Han","year":"2007","unstructured":"Han S, Roman J (2007) Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics? Anticancer Drugs 18:237\u2013244","journal-title":"Anticancer Drugs"},{"key":"9313_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1023\/A:1015670126203","volume":"20","author":"MR Smith","year":"2002","unstructured":"Smith MR, Kantoff PW (2002) Peroxisome proliferator-activated receptor gamma (PPargamma) as a novel target for prostate cancer. Invest New Drugs 20:195\u2013200","journal-title":"Invest New Drugs"},{"key":"9313_CR19","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1101\/gad.1424006","volume":"20","author":"K Willert","year":"2006","unstructured":"Willert K, Jones KA (2006) Wnt signaling: is the party in the nucleus? Genes & Dev 20:1394\u20131404","journal-title":"Genes & Dev"},{"key":"9313_CR20","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1093\/hmg\/ddn208","volume":"17","author":"M Lal","year":"2008","unstructured":"Lal M, Song X, Pluznick JL, Di Giovanni V, Merrick DM, Rosenblum ND, Chauvet V, Gottardi CJ, Pei Y, Caplan MJ (2008) Polycystin-1 C-terminal tail associates with beta-catenin and inhibits canonical Wnt signaling. Hum Mol Genet 17:3105\u20133117","journal-title":"Hum Mol Genet"},{"key":"9313_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0960-9822(99)80091-8","volume":"9","author":"M Hart","year":"1999","unstructured":"Hart M, Concordet JP, Lassot I, Albert I, del los Santos R, Durand H, Perret C, Rubinfeld B, Margottin F, Benarous R, Polakis P (1999) The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol 9:207\u2013210","journal-title":"Curr Biol"},{"key":"9313_CR22","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0092-8674(02)00685-2","volume":"108","author":"C Liu","year":"2002","unstructured":"Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X, He X (2002) Control of beta-catenin phosphorylation\/degradation by a dual-kinase mechanism. Cell 108:837\u2013847","journal-title":"Cell"},{"key":"9313_CR23","doi-asserted-by":"publisher","first-page":"18688","DOI":"10.1073\/pnas.0708217104","volume":"104","author":"S Yu","year":"2007","unstructured":"Yu S, Hackmann K, Gao J, He X, Piontek K, Germino GG (2007) Essential role of cleavage of Polycystin-1 at G protein-coupled receptor proteolytic site for kidney tubular structure. Proc Natl Acad Sci USA 104:18688\u201318693","journal-title":"Proc Natl Acad Sci USA"},{"key":"9313_CR24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1152\/ajprenal.00310.2002","volume":"283","author":"M Loghman-Adham","year":"2003","unstructured":"Loghman-Adham M, Nauli SM, Soto CE, Kariuki B, Zhou J (2003) Immortalized epithelial cells from human autosomal dominant polycystic kidney cysts. Am J Physiol Renal Physiol 283:397\u2013412","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-009-9313-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-009-9313-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-009-9313-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-009-9313-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T04:43:16Z","timestamp":1678509796000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-009-9313-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,16]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["9313"],"URL":"https:\/\/doi.org\/10.1007\/s10637-009-9313-x","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,16]]},"assertion":[{"value":"26 June 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}